Neuropsychological impairment among asymptomatic HIV-positive former intravenous drug users.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cognitive and Behavioral Neurology

• Publication date

  2006-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.WNN.0000182832.54697.5C
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Estudio de la afectación neuropsicológica asociada al VIH: revisión de aspectos metodológicos

  2003cited by this paper
• Neuropsychological Performance in HIV/AIDS Intravenous Drug Users

  2003cited by this paper
• Neuropsychological deficits and opiate abuse.

  2002cited by this paper
• Factors Affecting Cognitive Functioning in a Sample of Human Immunodeficiency Virus-Positive Injection Drug Users

  2002cited by this paper
• Cognitive impairment in methadone maintenance patients.

  2002cited by this paper
• Opioids, immunology, and host defenses of intravenous drug abusers.

  2002cited by this paper
• Methadone enhances human immunodeficiency virus infection of human immune cells.

  2002cited by this paper
• Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors.

  2002cited by this paper
• Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

  2002cited by this paper
• Influencia de factores relacionados con la infección en el rendimiento neuropsicológico de seropositivos al VIH

  2002cited by this paper
• Methadone may promote HIV replication: study.

  2001cited by this paper
• Investigating the neurocognitive deficits associated with chronic drug misuse.

  2001cited by this paper
• Long‐term methadone treatment: effect on CD4+ lymphocyte counts and HIV‐1 plasma RNA level in patients with HIV infection

  2001cited by this paper
• Cognitive-Motor Performance of Methadone-Maintained Patients

  2000cited by this paper
• Cognitive Function in HIV‐1‐Infected Drug Users

  2000cited by this paper
• Factors associated with neuropsychological performance in HIV-seropositive subjects without AIDS

  2000cited by this paper
• Neurobehavioural consequences of substance abuse and HIV infection

  2000cited by this paper
• Verbal working memory in HIV-seropositive drug users

  2000cited by this paper
• Slowed Reaction Time in HIV-1-Seropositive Intravenous Drug Users without AIDS

  2000cited by this paper
• Cognitive impairment among methadone maintenance patients.

  2000cited by this paper
• Bilateral symmetrical enhancing brainstem lesions: an unusual presentation of primary CNS lymphoma

  1999cited by this paper
• Assessment of Cognitive Function in Asymptomatic HIV-Positive Subjects

  1999cited by this paper
• Early neuropsychological impairment in HIV‐seropositive intravenous drug users: evidence from the Italian Multicentre Neuropsychological HIV Study

  1998cited by this paper
• Neuropsychological functioning in drug abusers.

  1998cited by this paper
• Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment.

  1998cited by this paper
• Neuropsychological abnormalities among HIV-infected individuals in a community-based sample.

  1997cited by this paper
• Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome

  1997cited by this paper
• Longitudinal neuropsychological evaluation of HIV-infected intravenous drug users.

  1996cited by this paper
• Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection.

  1996cited by this paper
• Neuropsychological changes in a prospectively followed cohort of intravenous drug users with and without HIV

  1996cited by this paper
• The Edinburgh cohort of HIV-positive drug users: The effects of depressed mood and drug use upon neuropsychological function

  1996cited by this paper
• Neurologic signs and symptoms in a cohort of homosexual men followed for 4.5 years

  1995cited by this paper
• Do asymptomatic HIV-seropositive individuals show cognitive deficit?

  1995cited by this paper
• A Review of the Effects of Opioids on Psychomotor and Cognitive Functioning in Humans

  1995cited by this paper
• Neuropsychological studies of asymptomatic Human Immunodeficiency Virus-Type-1 infected individuals

  1995cited by this paper
• HIV infection and drug use: influence on cognitive function

  1995cited by this paper
• The HNRC 500-Neuropsychology of Hiv infection at different disease stages

  1995cited by this paper
• A follow‐up study of neuropsychological functioning in AIDS‐patients Prognostic significance and effect of zidovudine therapy

  1995cited by this paper
• The effect of methadone on immunological parameters among HIV-positive and HIV-negative drug users.

  1994cited by this paper
• Zidovudine reduces intrathecal immunoactivation in patients with early human immunodeficiency virus type 1 infection.

  1994cited by this paper
• WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings.

  1994cited by this paper
• Relationship of beta 2 microglobulin and CD4 counts to neuropsychological performance in HIV-1-infected intravenous drug users.

  1994cited by this paper
• Methodologic issues in neuropsychological research with HIV-spectrum disease

  1993cited by this paper
• Cognitive behavior in asymptomatic (CDC stage II and III) HIV — seropositive intravenous drug users (IVDUs)

  1993cited by this paper
• Immune function and neuropsychological performance in HIV-1-infected homosexual men.

  1993cited by this paper
• Neuropsychological deficits in HIV-1 seropositive and seronegative intravenous drug users.

  1993cited by this paper
• Neuropsychological performance in HIV‐1‐infected drug abusers

  1993cited by this paper
• Neuropsychological abnormalities in AIDS and asymptomatic HIV seropositive patients.

  1993cited by this paper
• Neuropsychological performance in asymptomatic HIV infection.

  1992cited by this paper
• Neuropsychological impairment among intravenous drug users in pre-AIDS stages of HIV infection.

  1992cited by this paper
• Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity.

  1992cited by this paper
• The neuropsychological consequences of HIV infection in drug addicts

  1992cited by this paper
• Neuropsychological aspects of HIV infection.

  1992cited by this paper
• Neurologic and neuropsychological manifestations of human immunodeficiency virus infection in intravenous drug users without acquired immunodeficiency syndrome. Relationship to head injury.

  1992cited by this paper
• Cognitive abnormalities and disease progression in a selected population of asymptomatic HIV-positive subjects.

  1991cited by this paper
• Rate of CD4 decline and neuropsychological performance in HIV infection.

  1991cited by this paper
• HIV‐1 infection and nervous system abnormalities among a cohort of intravenous drug users

  1991cited by this paper
• The importance of confounding factors in the evaluation of neuropsychological changes in patients infected with human immunodeficiency virus.

  1990cited by this paper
• A prospective comparison of neuropsychologic function in HIV-seropositive and seronegative methadone-maintained patients.

  1990cited by this paper
• The Edinburgh cohort of HIV-positive drug users: current intellectual function is impaired, but not due to early AIDS dementia complex.

  1990cited by this paper
• Assessment of AIDS-related cognitive changes: recommendations of the NIMH Workshop on Neuropsychological Assessment Approaches.

  1990cited by this paper
• A prospective longitudinal study of neuropsychological and psychosocial factors in asymptomatic individuals at risk for HTLV-III/LAV infection in a methadone program: preliminary findings.

  1987cited by this paper
• Neuropsychiatric Aspects of Acquired Immune Deficiency Syndrome

  1984cited by this paper
• Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients

  1983cited by this paper
• Neurological complications now characterizing many AIDS victims.

  1982cited by this paper
• Digit-symbol performance in methadone-treated ex-heroin addicts.

  1976cited by this paper
• Physiological and psychological effects of methadone in man.

  1975cited by this paper
• The assessment and analysis of handedness: the Edinburgh inventory.

  1971cited by this paper
• A STUDY OF DETERMINE POSSIBLE DIFFERENCES IN THE FORMED BLOOD ELEMENTS OF NORMAL AND SCHIZOPHRENIC SUBJECTS.

  1963cited by this paper

• HIV-Related Neurocognitive Disorders and Drugs of Abuse: Mired in Confound, Surrounded by Risk

  2014cites this paper
• Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

  2012cites this paper
• Neurocognitive Impact of Substance Use in HIV Infection

  2011cites this paper
• Neuropsychological impairment and gender differences in HIV‐1 infection

  2008cites this paper
• Neuropsychological impairment and the natural history of HIV-1 infection in Spanish subjects.

  2007cites this paper
• Interactions of HIV and methamphetamine: Cellular and molecular mechanisms of toxicity potentiation

  2007cites this paper